Viewing Study NCT00908869


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-01-23 @ 1:46 AM
Study NCT ID: NCT00908869
Status: COMPLETED
Last Update Posted: 2012-01-30
First Post: 2009-05-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm
Sponsor: Institut Paoli-Calmettes
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced neoplasm View
None adult advanced neoplasm View